A team of epidemiologists at the First Hospital of Hebei Medical University, in China, has shown experimental evidence of an inverse relationship between incidences of…
Research using participants from one of Australia’s largest and longest running studies of aging has looked at the impact of mild cognitive impairment and dementia…
A new Research Letter published in Palliative Medicine estimates that the palliative care needs of people living with dementia in England and Wales will be…
Scientists have developed new potential therapies that selectively remove aggregated tau proteins, which are associated with Alzheimer’s disease, and improve symptoms of neurodegeneration in mice.
Patients regularly show up at university hospitals with diseases so rare and specific as to be scarcely known to physicians in private practice. Primary 4-repeat…
A lack of diversity in genomic studies for dementia could limit the effectiveness of targeted therapies across underrepresented populations, finds research by UCL experts.
A study published in the journal Brain shows that increases in protein levels with new Alzheimer’s drugs can explain the slowing of cognitive impairment at…
Researchers have for the first time identified degeneration-associated “molecular markers”—observable changes in cells and their gene-regulating networks—that are shared by several forms of dementia that…
The aging process can lead to diminished cognitive functioning for older adults. In addition, about 10 percent of people previously diagnosed with mild cognitive impairment…
There’s no question we’ve reached a turning point for Alzheimer’s disease treatment.